LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,071 | 8,668 | 7,995 | 5,610 | 10,070 |
| Marketable Securities | 32,240 | 17,355 | 30,660 | 47,115 | 55,343 |
| TOTAL | $40,518 | $27,355 | $39,996 | $53,444 | $66,738 |
| Non-Current Assets | |||||
| PPE Net | 6,406 | 6,471 | 6,591 | 6,034 | 4,454 |
| Intangibles | 2,743 | 2,694 | 2,512 | 2,386 | 2,427 |
| TOTAL | $9,149 | $9,165 | $9,103 | $8,420 | $6,881 |
| Total Assets | $49,667 | $36,520 | $49,099 | $61,864 | $73,619 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 471 | 998 | 3,584 | 1,846 | 1,716 |
| Accrued Expenses | 2,331 | 2,743 | 3,648 | 4,614 | 3,999 |
| TOTAL | $3,600 | $4,458 | $7,737 | $6,954 | $6,014 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,457 | 1,538 | 1,013 | 1,111 | 694 |
| TOTAL | $1,500 | $1,538 | $1,013 | $1,111 | $694 |
| Total Liabilities | $5,100 | $5,996 | $8,750 | $8,065 | $6,708 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,888 | 42,659 | 42,551 | 42,483 | 42,312 |
| Common Shares | 509 | 427 | 426 | 425 | 424 |
| Retained earnings | -183,965 | -177,031 | -167,108 | -153,567 | -140,408 |
| Other shareholders' equity | -74 | 2 | 26 | 36 | 78 |
| TOTAL | $44,567 | $30,524 | $40,349 | $53,799 | $66,911 |
| Total Liabilities And Equity | $49,667 | $36,520 | $49,099 | $61,864 | $73,619 |